Rufini, Vittoria
 Distribuzione geografica
Continente #
NA - Nord America 9.034
EU - Europa 8.491
AS - Asia 6.495
SA - Sud America 1.179
AF - Africa 158
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 7
Totale 25.385
Nazione #
US - Stati Uniti d'America 8.790
DE - Germania 3.397
SG - Singapore 2.874
CN - Cina 1.710
BR - Brasile 966
SE - Svezia 952
IT - Italia 738
VN - Vietnam 598
UA - Ucraina 561
FR - Francia 548
GB - Regno Unito 418
NL - Olanda 414
PL - Polonia 403
IE - Irlanda 330
IN - India 289
FI - Finlandia 280
ID - Indonesia 180
RU - Federazione Russa 153
JP - Giappone 148
BD - Bangladesh 130
TR - Turchia 117
HK - Hong Kong 113
CA - Canada 110
AR - Argentina 81
MX - Messico 73
IQ - Iraq 59
ES - Italia 52
AT - Austria 51
BE - Belgio 50
ZA - Sudafrica 47
PK - Pakistan 35
CH - Svizzera 27
KR - Corea 26
EC - Ecuador 25
JO - Giordania 22
SA - Arabia Saudita 22
VE - Venezuela 21
AE - Emirati Arabi Uniti 19
CI - Costa d'Avorio 19
CO - Colombia 19
IR - Iran 18
PH - Filippine 18
PY - Paraguay 18
LT - Lituania 17
AU - Australia 16
UZ - Uzbekistan 16
CL - Cile 15
UY - Uruguay 15
JM - Giamaica 14
AZ - Azerbaigian 13
KE - Kenya 13
MA - Marocco 13
CZ - Repubblica Ceca 12
IL - Israele 12
AL - Albania 11
PE - Perù 11
DK - Danimarca 10
EG - Egitto 10
ET - Etiopia 10
MY - Malesia 10
TN - Tunisia 9
NP - Nepal 8
HU - Ungheria 7
KZ - Kazakistan 7
MD - Moldavia 7
OM - Oman 7
PT - Portogallo 7
TT - Trinidad e Tobago 7
BO - Bolivia 6
CR - Costa Rica 6
DO - Repubblica Dominicana 6
DZ - Algeria 6
GA - Gabon 6
GR - Grecia 6
HN - Honduras 6
NG - Nigeria 6
RO - Romania 6
RS - Serbia 6
GT - Guatemala 5
PA - Panama 5
SN - Senegal 5
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
GE - Georgia 4
LK - Sri Lanka 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
AM - Armenia 3
BY - Bielorussia 3
EE - Estonia 3
KW - Kuwait 3
MM - Myanmar 3
NZ - Nuova Zelanda 3
SV - El Salvador 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BG - Bulgaria 2
BS - Bahamas 2
CG - Congo 2
Totale 25.332
Città #
Singapore 1.550
Chandler 1.240
Ashburn 951
San Jose 825
Amsterdam 367
Warsaw 363
Jacksonville 334
Dublin 325
Beijing 288
San Mateo 254
Munich 243
Ann Arbor 231
New York 220
Los Angeles 218
Nanjing 218
Frankfurt am Main 206
Ho Chi Minh City 202
Nürnberg 199
Jakarta 162
Hefei 159
Dearborn 157
Wilmington 156
Hanoi 152
Lauterbourg 149
The Dalles 146
Rome 143
Helsinki 136
Houston 134
Tokyo 128
Boston 123
Milan 123
Woodbridge 122
Fairfield 109
Hong Kong 103
Dallas 95
Seattle 94
Cattolica 91
Marseille 90
Nanchang 88
São Paulo 84
Bremen 80
Lawrence 75
Moscow 75
Chicago 74
Santa Clara 73
Redwood City 72
Izmir 67
Princeton 64
St Louis 63
Zhengzhou 63
Lancaster 62
Buffalo 59
Hyderabad 58
Boardman 54
Redmond 52
Brussels 47
Hebei 47
Kent 46
Shanghai 46
Kunming 41
Toronto 41
Brooklyn 40
London 40
Tianjin 40
Mountain View 38
Council Bluffs 37
Nuremberg 33
Orem 33
Atlanta 32
Changsha 32
Da Nang 31
Phoenix 31
Guangzhou 30
Rio de Janeiro 30
Cambridge 29
Leawood 28
Mexico City 28
Shenyang 27
Detroit 26
Jiaxing 26
Johannesburg 26
Montreal 26
Seoul 26
University Park 26
Belo Horizonte 25
Paris 25
Brasília 24
Chennai 24
Haiphong 24
Norwalk 23
San Francisco 23
Stockholm 22
Amman 21
Denver 21
Vienna 21
Düsseldorf 20
Jinan 20
Pune 20
Abidjan 19
Fremont 19
Totale 13.303
Nome #
Clinical impact of SARS-CoV-2 infection among patients with vulvar cancer: the Gemelli Vul.Can multidisciplinary team 947
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 366
Severe thyrotoxicosis due to functioning pulmonary metastases of well-differentiated thyroid cancer 353
Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients 303
18F-fluoro-deoxy-glucose focal uptake in very small pulmonary nodules: fact or artifact? Case reports 291
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 288
Markedly Increased 18F-FDG Uptake in a Nonfunctioning Adrenal Adenoma Mimicking Malignancy 280
A phase II study of sunitinib in advanced hepatocellular carcinoma 280
Incidentally discovered adrenal masses: a functional and morphological study 264
Renal artery stenting in patients with chronic ischemic heart disease 243
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 237
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 236
Radio-guided surgery for lymph node recurrences of differentiated thyroid cancer 230
Evaluation of the surgical completeness after total thyroidectomy for differentiated thyroid carcinoma. 230
Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors 222
Are the simplified methods to estimate Ki in 18F-FDG PET studies feasible in clinical routine? Comparison between three simplified methods. 220
[Contribution of nuclear medicine to the diagnosis of silent adrenal masses] 216
A prospective analysis of ¹⁸F-FDG PET/CT in patients with uveal melanoma: comparison between metabolic rate of glucose (MRglu) and standardized uptake value (SUV) and correlations with histopathological features. 214
Radiolabeled somatostatin analog scintigraphy in medullary thyroid carcinoma and carcinoid tumor 201
Oncologic outcomes in advanced laryngeal squamous cell carcinomas treated with different modalities in a single institution: a retrospective analysis of 65 cases 199
Diagnostic imaging in thyrotoxicosis 191
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 191
Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography 191
A Rare Case of Ectopic Adrenocorticotropic Hormone Syndrome Caused by a Metastatic Neuroendocrine Tumor of the Pancreas Detected by 68Ga-DOTANOC and 18F-FDG PET/CT 190
(18)F-Fluorodeoxyglucose positron emission tomography in evaluating treatment response to imatinib or other drugs in gastrointestinal stromal tumors: a systematic review 188
Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma 187
Oncological outcome in advanced laryngeal cancers treated with different modalities in a single institution. A retrospective analysis on 65 cases. 186
Treatment of advanced neuroblastoma in children over 1 year of age: The critical role of (131) I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen. 184
Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography. 184
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 183
Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography 182
Diagnostic imaging of euthyroid goiter 181
A NEW APPROACH IN THE TREATMENT OF STAGE-IV NEUROBLASTOMA USING A OMBINATION OF {[I-131] METAIODOBENZYLGUANIDINE (MIBG) AND CISPLATIN} 181
Imaging techniques for the evaluation of cervical cancer 181
Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type: results of a prospective study 179
Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type: results of a prospective study. 174
Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? 173
Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literature 173
Taralli S, Sollini M, Milella M, Perotti G, Filice A, Menga M, Versari A, Rufini V. (18)F-FDG and (68)Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study. 173
Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? 171
Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type: results of a prospective study 171
Scintigraphic localization of a disseminated malignant pheochromocytoma with the use of 131I-meta-iodobenzylguanidine 170
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 170
Comparison of metaiodobenzylguanidine scintigraphy with positron emission tomography in the diagnostic work-up of pheochromocytoma and paraganglioma: a systematic review. 170
imaging of peritoneal carcinomatosis with FDG PET-CT: diagnostic patterns, case examples and pitfalls 168
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 167
The impact of the COVID-19 pandemic on oncological disease extent at FDG PET/CT staging: the ONCOVIPET study 167
Primary multifocal lymphoma of peripheral nervous system: Case report and review of the literature 165
Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET). 163
Liver metastases of endocrine tumour associated with multiple endocrine neoplasia type 1: a sustained response to interferon therapy or a peculiar benign course? 162
Pharmacological interference with 123I-metaiodobenzylguanidine: a limitation to developing cardiac innervation imaging in clinical practice? 162
Cardiac metastases of Ewing sarcoma detected by 18F-FDG PET/CT 161
Optimal use of the 131-I-metaiodobenzylguanidine and cisplatin combination in advanced neuroblastoma 161
Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumors: a meta-analysis 161
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 161
Lung uptake of fluorine-18 fluoroethyl-choline PET-CT in patients with prostate cancer 160
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 159
The impact of the COVID-19 pandemic on oncological disease extent at FDG PET/CT staging: the ONCOVIPET study 159
Diagnostic imaging of the thyroid: metodology and norma patterns 156
Diagnostic approach, genetic screening and prognostic factors of medullary thyroid carcinoma 156
Role of PET/CT in the functional imaging of endocrine pancreatic tumors 156
Cushing's syndrome due to a bronchial ACTH-secreting carcinoid successfully treated with radio frequency ablation (RFA) 156
Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid 156
Groin sentinel node biopsy and18F-FDG PET/CT-supported preoperative lymph node assessment in cN0 patients with vulvar cancer currently unfit for minimally invasive inguinal surgery: The GroSNaPET study 156
FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET) 156
The role of positron emission tomography using carbon-11 and fluorine-18 choline in tumors other than prostate cancer: a systematic review 154
Physiological Activity of Spinal Cord in Children: An 18F-FDG PET-CT Study 154
Masking effect of chronic pancreatitis in the interpretation of somatostatin receptor positron emission tomography in pancreatic neuroendocrine tumors. 153
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 151
PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery 150
Diagnostic performance of (18)F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis 149
Recurrence in region of spared parotid gland in patient receiving definitive intensity-modulated radiotherapy for nasopharyngeal cancer: A case report 149
Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma 149
The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study 149
Thyroid carcinomas with a variable insular component: prognostic significance of histopathologic patterns 148
An unusual case of adrenal metastasis from colorectal cancer: computed tomography and fluorine 18-fluoro-deoxy-glucose positron emission tomography-computed tomography features and literature review 148
Thyrotoxicosis due to ectopic retrotracheal adenoma treated with radioiodine 148
Imaging in endocrinology: 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in differentiated thyroid carcinoma: clinical indications and controversies in diagnosis and follow-up 148
18F-FDG PET and 18F-FDG PET/CT in Vulvar Cancer: A Systematic Review and Meta-analysis 147
A standardized dual-phase 18F-DOPA PET/CT protocol in the detection of medullary thyroid cancer 146
Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden 144
99mTc-Tilmanocept performance for sentinel node mapping in breast cancer, melanoma, and head and neck cancer: a systematic review and meta-analysis from a European expert panel 143
Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study 143
Detection Rate of Recurrent Medullary Thyroid Carcinoma Using Fluorine-18 Dihydroxyphenylalanine Positron Emission Tomography: A Meta-analysis 143
A Rare Case of Solitary Fibrous Tumor of the Adrenal Gland Detected by 18F-FDG PET/CT 143
Radiolabeled mataiodobenzylguanidine in the diagnosis of neural crest tumors 142
Multifocal Extra-Adrenal Paraganglioma Evaluated With Different PET Tracers: Comparison Between 18F-FDG, 18F-DOPA and 68Ga DOTANOC PET/CT 142
CRITICAL OBSERVATIONS ON NEUROBLASTOMA TREATMENT WITH 131-I-METAIODOBENZYLGUANIDINE AT DIAGNOSIS 141
Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3 141
Multidisciplinary Tumor Board Smart Virtual Assistant in Locally Advanced Cervical Cancer: A Proof of Concept 141
Role of 18F-FDG PET/CT in Head and Neck Squamous Cell Carcinoma: Current Evidence and Innovative Applications 140
Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma 140
Evaluating the Risk of Inguinal Lymph Node Metastases before Surgery Using the Morphonode Predictive Model: A Prospective Diagnostic Study in Vulvar Cancer Patients 139
Imaging of gynecologic malignancies with FDG PET-CT: case examples, physiologic activity, and pitfalls 139
The accessory spleen is an important pitfall of 68Ga-DOTANOC PET/CT in the workup for pancreatic neuroendocrine neoplasm 139
Which imaging technique should we use in the follow up of gynaecological cancer? 137
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma 135
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 134
A rare case of synchronous bilateral pulmonary neuroendocrine tumor detected by 68Ga-DOTANOC PET/CT 134
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma 134
Totale 18.549
Categoria #
all - tutte 94.634
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.634


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.355 123 124 11 93 101 44 29 209 69 63 193 296
2022/20233.245 383 450 199 548 174 409 162 288 381 58 110 83
2023/20241.377 75 421 43 63 43 200 45 67 23 85 161 151
2024/20253.313 79 74 243 120 313 147 151 200 540 294 616 536
2025/20269.287 1.181 281 466 977 1.495 1.197 1.532 442 583 635 259 239
2026/2027189 189 0 0 0 0 0 0 0 0 0 0 0
Totale 25.644